Spiramycin

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Macrolide antibiotic.

Half-lifeThis section has been translated automatically.

3–4 h

Spectrum of actionThis section has been translated automatically.

According to erythromycin, no effect on H. influenzae. In high dosage effectiveness against Toxoplasma gondii.

IndicationThis section has been translated automatically.

Tonsillitis, pharyngitis, otitis media, skin and soft tissue infections, toxoplasmosis, especially during pregnancy.

Dosage and method of useThis section has been translated automatically.

  • General infections:
    • Adults: 6 million IU/day p.o. in 2-4 ED. For severe infections up to 12 million IU/day
    • Infants and children < 6 years.: 4 times/day 40.000 IU/kg KG p.o.
  • Toxoplasmosis:
    • adults: 9 million IU/day p.o. in 2-4 ED.
    • children in 1st year: 300 000 IU/kg bw.

Undesirable effectsThis section has been translated automatically.

S.u. Erythromycin. Less severe gastrointestinal side effects than erythromycin.

PreparationsThis section has been translated automatically.

selectomycin, rovamycins

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer